
P1: FCG/SPH P2: FCG/SPH QC: FCG/SPH T1: SPH
JWBK011-14 JWBK011-Hogg August 12, 2005 16:32 Char Count= 0
356 ANTIMICROBIAL AGENTS
Box 14.2 Was Fleming lucky?
In the frequent retelling of the discovery of penicillin, much is made of the role
played by chance. It is true that the Penicillium mould in Fleming’spetri dish was an
accidental contaminant, but arguably the real stroke of luck was not so much the
fact that the contamination occurred but that it was observed by somebody who
immediately recognised its significance.
centuries can, with the benefit of hindsight, be regarded as a form of antibiotic therapy.
Many hundreds of years ago for example, the Chinese used mouldy soybean curd in the
treatment of boils and South American Indians controlled foot infections by wearing
sandals which had become furry with mould! In the late 19th century, Tyndall (see
Chapter 13) made the observation that a culture medium cloudy with bacterial growth
would clear when mould grew on the surface. Around the same time Pasteur and Joubert
demonstrated that cultured anthrax bacilli could be inactivated in the presence of certain
other microorganisms from the environment. By the early 1920s the search was on for
the isolation of a microbially produced antibacterial agent, and Gratia and Dath isolated
a substance from a soil actinomycete which came to be known as actinomycin. However,
although potent against a number of pathogens, actinomycin is too toxic to be useful
therapeutically.
Fleming was also looking for a naturally occurring antimicrobial agent. On one occa-
sion, he noticed that a plate culture of Staphylococcus aureus had become contaminated
by the growth of a mould; around it were clear areas, where the S. aureus did not grow.
The mould was subsequently identified as Penicillium notatum. and the substance that
had diffused through the agar from it, preventing bacterial growth, became known
as penicillin. Further investigation revealed that broth from a culture of the Penicil-
lium mould was inhibitory towards the growth of a number of other Gram-positive
pathogens, and remained so even when diluted several hundred times. Critically, when
tested on mice, it was, for the most part, harmless.
When it came to purifying the active ingredient and using it in vivo however, a num-
ber of problems were encountered. The penicillin proved to be impure, only produced in
minute amounts, and unstable in the acid conditions of the stomach, thereby limiting its
therapeutic potential. After publishing a few papers on the subject, Fleming ceased work
on penicillin and it was left to Howard Florey and Ernst Chain in 1939 to take up the
challenge of producing it in sufficient quantities and in a pure enough form for therapeu-
tic use. Early work in Oxford had to continue in the United States because of the German
air raids in Britain. The American entry into the Second World War in late 1941 meant
that the development of penicillin was awarded war project status, giving it greatly
added impetus. As a result of their endeavours, the yield of penicillin rose hugely (see
Box 14.3), and in 1945, Fleming, Chain and Florey shared the Nobel Prize for their work.
Other antibiotics were also isolated during this period, most notably streptomycin,
isolated by Selman Waksman from Streptomyces griseus, which was to prove so effective
against tuberculosis.
In 1942 there was only enough penicillin in the world to treat a few hundred in-
dividuals, but by the end of the Second World War production had grown to such an
extent that 7 million people a year could be treated. By the mid-1950s, such well-known